Director/PDMR Shareholding

GlaxoSmithKline PLC 11 July 2005 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned persons on 11 July 2005 of an increase in their notional interests in Ordinary Shares at a price of £13.39 per Ordinary Share and Ordinary Share ADRs at a price of $49.95 per ADR following the notional re-investment of the dividend paid to shareholders on 7 July 2005: Dr J P Garnier 3,131.377 ADRs Mr J Heslop 116.870 Ordinary Shares Dr T Yamada 939.413 ADRs Mr R Bondy 1,183.698 Ordinary Shares Mr W Calhoun 391.423 ADRs Mr M Dunoyer 445.808 Ordinary Shares Mr R Greig 391.423 ADRs Mr D Phelan 602.79 ADRs Dr D Pulman 391.634 Ordinary Shares 192.018 ADRs Mr D Stout 1,158.609 ADRs Mr C Viehbacher 602.79 ADRs Mr A Witty 1,042.709 Ordinary Shares Mrs J Younger 269.022 Ordinary Shares Mr J Ziegler 602.79 ADRs The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period. This notification relates to a transaction notified in accordance with Disclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b). S M Bicknell Company Secretary 11 July 2005 This information is provided by RNS The company news service from the London Stock Exchange VFLFFEDBFBBZ

Companies

GSK (GSK)
UK 100